Showing 34,877 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

New & experimental hepatitis C treatment

AbbVie combination cures 95% of genotype 3 hepatitis C

News
21 April 2017
Access to healthcare

The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir

Editor's pick
Medicines Patent Pool
21 April 2017
New & experimental hepatitis C treatment

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

News
21 April 2017
Hepatitis C treatment

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

News
21 April 2017
Hepatitis C treatment

European HCV treatment access survey shows big variations in eligibility

News
20 April 2017
Hepatitis C treatment

Curing hepatitis C reduces cardiovascular risk

News
20 April 2017
Pregnancy and vertical transmission

The living legacy of the Global Plan: eliminating HIV in children

Editor's pick
UNAIDS
20 April 2017
PrEP

Anti-HIV drug removes personal responsibility

Editor's pick
Irish Times
20 April 2017
Hepatitis C symptoms & diagnosis

Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease

Editor's pick
EASL press release
20 April 2017
Global health targets

Monitoring of progress towards 90-90-90 blighted by poor quality reporting

News
20 April 2017
The search for a cure

Defective HIV proviruses hinder immune system response and cure

Editor's pick
Science Daily
19 April 2017
Hepatitis C treatment

Hepatitis C treatment can be provided successfully at syringe programme sites

News
19 April 2017
Global health initiatives

The Future Of Investment In PEPFAR: Understanding PEPFAR’s Multiple Economic, Health, And Diplomatic Impacts

Editor's pick
Health Affairs
19 April 2017
PrEP

Open letter to Gilead Sciences about PrEP by EATG and the PrEP in Europe Initiative

Editor's pick
EATG / PrEP in Europe
18 April 2017
Pharmaceutical industry

Top 10 Pharmaceutical Companies 2017

Editor's pick
LinkedIn
18 April 2017
Pharmaceutical industry

Destroy Them: One Way to Up Price of Generic Cancer Drugs

Editor's pick
Medscape
18 April 2017
Mental & emotional health & wellbeing

Teaching happiness to men with HIV boosts their health

Editor's pick
Eurekalert Medicine & Health
18 April 2017
New & experimental HIV treatments

Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

Editor's pick
Cytodyn press release
18 April 2017
Taking an HIV test

HIV test kits sold in China's university vending machines at massive discount

Editor's pick
South China Morning Post
18 April 2017
Epidemiology

HIV notifications down 16 per cent in Queensland compared to same period in 2016

Editor's pick
Brisbane Times
18 April 2017
Infant feeding

Study shows that HIV-positive nursing mothers in London can struggle to obtain and afford formula milk

News
18 April 2017
Men who have sex with men (MSM)

Black HIV-positive MSM in US still have lower rates of ART use

News
17 April 2017
The search for a cure

Biomarker Opens New Door in HIV Cure Research

Editor's pick
MedPage Today HIV/AIDS
14 April 2017
Drug-resistant TB

Multidrug-resistant tuberculosis in migrants, multi-country cluster

Editor's pick
ECDC
14 April 2017